Top

Published in:

01-11-2016 | Original Article

Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients

Authors: N. Kazemikhoo, A. F. Sarafnejad, F. Ansari, P. Mehdipour

Published in: Lasers in Medical Science | Issue 8/2016

Abstract

The epidermal growth factor receptor (EGFR) signaling pathway may be involved in cell activation and may influence the neuronal microenvironment, microglia activation, and production of proinflammatory cytokines. Arginase and nitric oxide synthase (NOS) both use l-arginine as a common substrate. Decreasing the arginase expression may increase l-arginine consumption by NOS and increase nitric oxide (NO) synthesis. Intravenous laser blood irradiation (ILBI) is an effective systemic treatment for different pathologies including diabetes mellitus. Previous studies have shown that low-level laser therapy can have an effect on the release of certain cytokines and growth factors. The aim of this study was to evaluate the effects of ILBI on the expression of arginase and epidermal growth factor receptor in type 2 diabetic patients. We used 630 nm red laser light, 1.5 mW, continuous mode, intravenously for 30 min in 13 type 2 diabetic patients and compared their blood samples using the flow cytometry technique, before and after ILBI. The difference between the percentage of cells before and after therapy was analyzed using repeated-measures ANOVA, and the relationship between EGFR and arginase expression in blood and tissue was evaluated by calculating the Pearson correlation coefficient. We found a significant decrease in the expression of both arginase- and EGFR-positive cells after laser therapy (P < 0.01). In conclusion, laser therapy may have a beneficial effect for diabetic patients via decreasing arginase expression and activation of the NOS/NO pathway which increases NO production and vasodilation, and decreasing EGFR expression which may reduce neuroinflammation and its secondary damages.

Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347):317–325CrossRefPubMed

Group UPDS (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131):837–853CrossRef

Abergel RP, Meeker CA, Lam TS, Dwyer RM, Lesavoy MA, Uitto J (1984) Control of connective tissue metabolism by lasers: recent developments and future prospects. J Am Acad Dermatol 11(6):1142–1150CrossRefPubMed

Lyons RF, Abergel RP, White RA, Dwyer RM, Castel JC, Uitto J (1987) Biostimulation of wound healing in vivo by a helium-neon laser. Ann Plast Surg 18(1):47–50CrossRefPubMed

Rochkind S, Rousso M, Nissan M, Villarreal M, Barr‐Nea L, Rees D (1989) Systemic effects of low‐power laser irradiation on the peripheral and central nervous system, cutaneous wounds, and burns. Lasers Surg Med 9(2):174–182CrossRefPubMed

Liu TC-Y, Liu Y-Y, Wei E-X, Li F-H (2012) Photobiomodulation on stress. Int J Photoenerg

Kazemi-Khoo N (2006) Successful treatment of diabetic foot ulcers with low-level laser therapy. Foot 16(4):184–187CrossRef

AlGhamdi KM, Kumar A, Moussa NA (2012) Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells. Lasers Med Sci 27(1):237–249CrossRefPubMed

Khoo NK, Iravani A, Arjmand M, Vahabi F, Lajevardi M, Akrami S, Zamani Z (2013) A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients. Lasers Med Sci 28(6):1527–1532CrossRef

10.

KazemiKhoo N, Ansari F (2015) Blue or red: which intravascular laser light has more effects in diabetic patients? Lasers Med Sci 30(1):363–366CrossRefPubMed

11.

Chenzhong Y, Daping F, Xiaoning Z, Zhengrong H, Zuxuan Z (1998) Biological effects of intravascular low level laser irradiation with five different wave length. Appl Laser 2:012

12.

Weber M, Fußgänger-May T, Wolf T (2007) The intravenous laser blood irradiation. Introduction of a new therapy. Ger J Acupunct Relat Tech 50(3):12–23

13.

Gasparyan L (2003) Laser irradiation of the blood. Laser Partner-Clinixperience-All Volumes-2003:1–4

14.

Gasparyan LV, Brill G, Makela AM Activation of angiogenesis under influence of red low level laser radiation. In: Laser Florence 2004, 2005. Int Soc Optics Photonics:596806-596806-596806

15.

Khoo NK, Shokrgozar MA, Kashani IR, Amanzadeh A, Mostafavi E, Sanati H, Habibi L, Talebi S, Abouzaripour M, Akrami SM (2014) In vitro therapeutic effects of low level laser at mRNA level on the release of skin growth factors from fibroblasts in diabetic mice. Avicenna J Med Biotechnol 6(2):113PubMedPubMedCentral

16.

Kassab KN, Hassan AI, Khater MS, Elfouly SA (2013) Evaluating the regenerative potential of low level laser and/or epidermal growth factor therapies in cisplatin induced acute renal failure in rats. Int J Med Med Sci 46(1):1134

17.

Gao X, Xing D (2009) Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci 16(4):1–16

18.

Chen C-H, Hung H-S, S-h H (2008) Low-energy laser irradiation increases endothelial cell proliferation, migration, and eNOS gene expression possibly via PI3K signal pathway. Lasers Surg Med 40(1):46CrossRefPubMed

19.

Lakin RO, Zhu W, Feiten L, Kashyap VS (2013) Techniques to harvest diseased human peripheral arteries and measure endothelial function in an ex vivo model. J Vasc Surg 58(2):470–477CrossRefPubMedPubMedCentral

20.

Tesfamariam B, Cohen RA (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Phys Heart Circ Phys 263(2):H321–H326

21.

Durante W, Johnson FK, Johnson RA (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34(9):906–911CrossRefPubMedPubMedCentral

22.

Appleton I, Tomlinson A, Willoughby DA (1996) Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv Pharmacol (San Diego, Calif) 35:27

23.

Ash DE, Cox JD, Christianson DW (2000) Arginase: a binuclear manganese metalloenzyme. Met Ions Biol Syst 37:407–428PubMed

24.

Sikka G, Pandey D, Bhuniya AK, Steppan J, Armstrong D, Santhanam L, Nyhan D, Berkowitz DE (2013) Contribution of arginase activation to vascular dysfunction in cigarette smoking. Atherosclerosis 231(1):91–94CrossRefPubMed

25.

Xu W, Kaneko FT, Zheng S, Comhair SA, Janocha AJ, Goggans T, Thunnissen FB, Farver C, Hazen SL, Jennings C (2004) Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 18(14):1746–1748PubMed

26.

van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM (1997) Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95(4):1030–1037CrossRefPubMed

27.

Parenti A, Morbidelli L, Cui X-L, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M (1998) Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase½ activation in postcapillary endothelium. J Biol Chem 273(7):4220–4226CrossRefPubMed

28.

Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Investig 100(9):2153CrossRefPubMedPubMedCentral

29.

Makela AM Role of L-arginine in the biological effects of blue light. In: Laser Florence 2004, 2005. Int Soc Optics and Photonics, pp 596805-596805-596813

30.

Sharma K, Babu PC, Sasidhar P, Srinivas V, Mohan VK, Krishna E (2008) Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli. Protein Expr Purif 60(1):7–14CrossRefPubMed

31.

Holbro T, Hynes NE (2004) ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44:195–217CrossRefPubMed

32.

Kassenbrock CK, Hunter S, Garl P, Johnson GL, Anderson SM (2002) Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem 277(28):24967–24975CrossRefPubMed

33.

Erschbamer M, Pernold K, Olson L (2007) Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury. J Neurosci 27(24):6428–6435CrossRefPubMed

34.

Qu W, Tian D, Guo Z, Fang J, Zhang Q, Yu Z, Xie M, Zhang H, Lü J, Wang W (2012) Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury. J Neuroinflammation 9(178):2094–2099

35.

Ge H, Gong X, Tang CK (2002) Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis. Int J Cancer 98(3):357–361CrossRefPubMed

36.

VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V (2008) Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 7(10):1902–1924CrossRefPubMedPubMedCentral

37.

Khamseh ME, Kazemikho N, Aghili R, Forough B, Lajevardi M, Dabaghian FH, Goushegir A, Malek M (2011) Diabetic distal symmetric polyneuropathy: effect of low-intensity laser therapy. Lasers Med Sci 26(6):831–835CrossRefPubMed

38.

Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC (2001) Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 283(4):923–927CrossRefPubMed

39.

Shemyakin A, Kövamees O, Rafnsson A, Böhm F, Svenarud P, Settergren M, Jung C, Pernow J (2012) Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 126(25):2943–2950CrossRefPubMed

40.

Förstermann U, Münzel T (2006) Endothelial nitric oxide synthase in vascular disease from marvel to menace. Circulation 113(13):1708–1714CrossRefPubMed

41.

Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, Caldwell RB, Caldwell RW (2008) Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 102(1):95–102CrossRefPubMed

42.

Koprivica V, Cho K-S, Park JB, Yiu G, Atwal J, Gore B, Kim JA, Lin E, Tessier-Lavigne M, Chen DF (2005) EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310(5745):106–110CrossRefPubMed

43.

Cerniglia GJ, Pore N, Tsai JH, Schultz S, Mick R, Choe R, Xing X, Durduran T, Yodh AG, Evans SM (2009) Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One 4(8):e6539CrossRefPubMedPubMedCentral

44.

Ogita M, Tsuchida S, Aoki A, Satoh M, Kado S, Sawabe M, Nanbara H, Kobayashi H, Takeuchi Y, Mizutani K (2014) Increased cell proliferation and differential protein expression induced by low-level Er: YAG laser irradiation in human gingival fibroblasts: proteomic analysis. Lasers Med Sci:1–12

45.

Peplow PV, Chung T-Y, Ryan B, Baxter GD (2011) Laser photobiomodulation of gene expression and release of growth factors and cytokines from cells in culture: a review of human and animal studies. Photomed Laser Surg 29(5):285–304CrossRefPubMed

46.

Zhang Y, Song S, Fong C-C, Tsang C-H, Yang Z, Yang M (2003) cDNA microarray analysis of gene expression profiles in human fibroblast cells irradiated with red light. J Investig Dermatol 120(5):849–857CrossRefPubMed

47.

Conlan MJ, Rapley JW, Cobb CM (1996) Biostimulation of wound healing by low‐energy laser irradiation. A review. J Clin Periodontol 23(5):492–496CrossRefPubMed

Title: Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients
Authors: N. Kazemikhoo
A. F. Sarafnejad
F. Ansari
P. Mehdipour
Publication date: 01-11-2016
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 8/2016
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-016-2012-x

At a glance: The STEP trials

Springer Medicine

Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2016

Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients

A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway

Treatment of nasal ala nodular congenital melanocytic naevus with carbon dioxide laser and Q-switched Nd:YAG laser

Laser biostimulation of wound healing: bioimpedance measurements support histology

The invisible basal cell carcinoma: how reflectance confocal microscopy improves the diagnostic accuracy of clinically unclear facial macules and papules

What is the best moment to apply phototherapy when associated to a strength training program? A randomized, double-blinded, placebo-controlled trial